11 - Pediatric Diseases of the Liver Flashcards

(45 cards)

1
Q

Cholestasis

A
Impairment in bile flow
From:
Defects in intrahepatic production
Transmembrane transport
Mechanical obstruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cholestasis - Manifestations

A
Retention of bile components
Elevated serum bile acids - Pruritis
Hyperbilirubinemia - Jaundice
Hypercholesterolemia - Xanthomas
Impaired copper excretion - fibrosis
Neonatal cholestasis > 2 weeks affects 1 in 2500 births
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cholestasis Consequences - Impaired Bile Salt Excretion

A

Fat Malabsorption - Nutritional Impairment

Fat Soluble Vitamin Deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cholestasis Consequences - Hepatocellular Injury

A

Progressive fibrosis, evolving to cirrhosis
Portal hypertension
Loss of hepatic synthetic function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Most common cause of neonatal cholestasis, but least understood

A

Idiopathic Neonatal Hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Idiopathic Neonatal Hepatitis

A
30 - 40% of neonatal cholestasis
Jaundice in the first week of life
33% FTT or fulminant course
Hepatomegaly +/- Splenomegaly
Acholic stool possible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Two forms of Idiopathic Neonatal Hepatitis

A

Sporadic (60 - 70% full recovery)

Familial (20 - 30% recovery, 10 - 15% cirrhosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Idiopathic Neonatal Hepatitis - Pathology

A

Severe diffuse hepatocellular disease
Marked infiltration by inflammatory cells
Focal hepatocellular necrosis
GIANT CELL HEPATITIS

Not present:
Bile ductular proliferation
Bile duct paucity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Biliary Atresia

A

Uncommon
No familiar pattern
Icteric by first week
Acholic stools

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Biliary Atresia - Associated abnormalities

A

Polysplenia
Heterotaxia
Intra-abdominal vascular abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Biliary Atresia - Cause

A

Unknown

Can be induced via infectious agents (Reovirus III, CMV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Biliary Atresia - Investigations

A

Abdominal ultrasound (to rule out biliary obstruction like a choledochal cyst)
HIDA scan with phenobarb x 5D (good for ruling out)
Liver biopsy
Intra-op cholangiogram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If you give phenobarb to a pediatric patient, what are the two ways they can go about bile absorption?

A

Bile acid dependent (main/only pathway in adults)

Bile acid independent (about 10% of the pathway in kids, can induce this pathway with phenobarb)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Biliary Atresia - Pathology

A
Infantile obstructive cholangiopathy
Bile ductular proliferation
Portal expansion with edema +/- fibrosis
Bile plugs
Intact lobular architecture
Giant cells may be present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Biliary Atresia - Treatment

A

Kasai hepatic porto-enterostomy

Performed in the first few months of life (

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Alagille Syndrome

A
Autosomal Dominant
Arteriohepatic dysplasia
Variable penetrance
JAG 1 (notch ligand) mutation (>90%)
Chromosome 20p12
Intrahepatic interlobular bile duct paucity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Alagille syndrome - Abnormalities

A

Face - Broad forehead, underdeveloped mandible, straight nose (95%)
Ocular - Posterior embryotoxon - finding in the eye, doesn’t change vision(88%)
Cardiovascular - Peripheral Pulmonic Stenosis or Tetralogy of Fallot (85%)
Vertebral - Butterfly vertebrae (87%)
Minor abnormalities - Renal disease, short stature, pancreatic insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Alagille’s Syndrome - Prognosis

A

Prolonged survival good (80% without OLT)
Pruritus
Xanthoma - Lipoprotein X
Neurologic complications (Vitamin E deficiency)
Defective spermatogenesis
Growth retardation
CNS anyeurisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Progressive Familial Intrahepatic Cholestasis (PFIC)

A

Byler’s-like syndrome
Autosomal Recessive

PFIC-1 defect in P-type ATPase gene (ATP8B1)
FIC-1 gene localized to chromosome 18q21
Defect in biliary canalicular membrane phospholipid transport

PFIC-2 - defective bile salt export pump (BSEP) - You can stain for this on biopsy now!!

Normal GGTP (it’s a transport defect!)

Post transplant sometimes you end up with bile salty diarrhea

20
Q

Choledocal Cyst

A

Congenital biliary dilatation
Common bile duct affected
Cyst wall - fibrous tissue lacking epithelium
Malignant potential - Merits resection

Early

21
Q

Choledocal Cyst - Type 1

A

50 - 80%

Diffuse fusiform dilatation of the common bile duct

22
Q

Choledocal Cyst - Type 2

A

Diverticulum of common bile duct

23
Q

Choledocal Cyst - Type 3

A

Within the duodenal wall

24
Q

Choledocal Cyst - Type 4

A

Type 1 (diffuse fusiform dilatation) with intrahepatic duct cyst

25
Choledocal Cyst - Diagnosis
Abdominal ultrasound
26
Caroli's Disease
Cystic dilatation of intrahepatic ducts Not familial 75% male Usually present in childhood or early adult life Abdominal pain, hepatomegaly, gram (-) sepsis
27
Caroli's Disease - Diagnosis
Ultrasound, CT scan, ERCP, PTC Common bile duct normal, multiple saccular dilatations of intrahepatic ducts, can be unilateral Cholangiocarcinoma risk - 7% of patients
28
Caroli's Disease - Treatment
Stenting, suppressive antibiotics, pain meidcation
29
Gestational Alloimmune Liver Disease
Formerly known as neonatal hemochromatosis Hepatic failure (at birth!) and iron deposition Onset is intrauterine Anti-human C5B-9 complex - Transplacental IgG Activates fetal complement cascade Target protein not identified
30
Gestational Alloimmune Liver Disease - Treatment
IVIG and exchange transfusion Liver transplant if medical treatment fails Subsequent pregnancies treated with IVIG beginning at 18 weeks gestation (90% recurrence)
31
Infectious Hepatitis - Pathogens
``` Toxoplasmosis Rubella CMV Herpes Syphillis Coxsackie Echovirus (11, 14, 19) Adenovirus Parvovirus B19 EBV (unusual) ```
32
Alpha-1 Antitrypsin Deficiency
AAT serine protease inhibitor (PI) Accumulation of abnormal protein in ER PI phenotyping - defined by isoelectric focusing of plasma Gene on chromosome 14 with over 100 known mutations Most common allele causing liver disease is Z Transplant for severe liver disease / cirrhosis - 65% Risk of COPD with panlobular emphysema
33
Alpha-1 Antitrypsin Deficiency - Path
PAS+ Globules that resist diastase treatment
34
Parenteral Nutrition-Associated Liver Disease
Formerly TPN Cholestasis Range from mildly elevated LFTs and Fatty Liver to Frank Cirrhosis Cholestasis - Worse with time and lack of enteral stimulation Etiology unknown - Toxic bile acid metabolites, bacterial toxins, glucose concentration, free oxygen radicals from peroxidation of lipids
35
Parenteral Nutrition-Associated Liver Disease - Treatment
``` Feed, Cycle or stop TPN Reduce lipids Bowel in circuit STEP Ursodiol Bowel decontamination ```
36
Parenteral Nutrition-Associated Liver Disease - Biopsy
Indistinguishable from Biliary Atresia Bile plugs Ductular abnormalities
37
Tyrosinemia
Autosomal Recessive Lack fumaryl acetoacetate hydrolase (FAH) Metabolites toxic to liver and kidney (RTA) Neurologic impairment can occur Painful crises, mimicking porphyria HCC occur in >40% of cases
38
Tyrosinemia - Diagnosis
Elevated urinary succinyl acetone
39
Tyrosinemia - Treatment
NTBC/Orfadin | Specific inhibitor of tyrosine metabolism
40
Tyronsinemia - Cure
Transplant
41
Galactosemia
Autosomal recessive Lacking galactose-1-phosphate-uridyl transferase Diffuse hepatocellular fatty change
42
Galactosemia - Infant signs
Feeding problems, cataracts, vomiting, jaundice, diarrhea, ascites, HM, sepsis
43
Galactosemia - Diagnosis
+ Urine reducing substance, G1PUT levels
44
Galactosemia - Treatment
Withdrawal of dietary milk and milk products
45
Cholestasis - Overall management
Nutritional support (vitamin supplementation) Alleviate pruritus (Choleretic agents) Monitor growth, clinical and biochemical parameters Optimize psychosocial development Assess quality of live Gauge success, search for complications Disease specific therapy - diet, surgical palliation, medications Liver transplant